From Genentech β Oncology R&D Division Template by David Nagy Β· Templates
π SECTION 4: π Data Analysis & Results
Published
π Interim Results (Rolling)
- Efficacy metrics
- Kaplan-Meier curves
- Statistical significance
π Safety Profile Summary
- Side effects vs competitors
- Risk-benefit analysis
π Competitive Benchmarking
- Compared to Amgen / Mirati therapies
- Market positioning